PCSK9 Inhibitors - Alirocumab and Evolucumab: Key Insights on Differentiation in a Generic Market
Value in Health - United Kingdom
doi 10.1016/j.jval.2016.03.152
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2016
Authors
Publisher
Elsevier BV